| Institution: | 1. Department of Breast Surgery, Peking University Shenzhen Hospital, Shenzhen, China;2. Department of Breast Surgery, Peking University Shenzhen Hospital, Shenzhen, China
Department of Breast Surgery, Shenzhen Second People′s Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, China;3. Department of Breast Surgery, Shenzhen Second People′s Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen, China |
| Abstract: | Breast cancer is the most common cancer diagnosed in women. Breast cancer research is currently based mainly on animal models and traditional cell culture. However, the inherent species gap between humans and animals, as well as differences in organization between organs and cells, limits research advances. The breast cancer organoid can reproduce many of the key features of human breast cancer, thereby providing a new platform for investigating the mechanisms underlying the development, progression, metastasis and drug resistance of breast cancer. The application of organoid technology can also promote drug discovery and the design of individualized treatment strategies. Here, we discuss the latest advances in the use of organoid technology for breast cancer research. |
